Verra Therapeutics, Inc.
Form D Filings
Location
Lansing, NY
Industry Group
Biotechnology
Related People
Christopher Lucas Prince
,
Jeffrey Calkins
Entity Type
Corporation
CIK
0002111997
All SEC Filings
View on sec.gov
Date Filed
Security Types
Total Amount Sold
Total Offering
Amount Remaining
First Sale
Signed
Form
SEC Link
2/18/2026
Equity
$205,000
$450,000
$245,000
12/16/2024
2/18/2026
D
000211199726000001